ovarian cancer

News

ESMO26: Lilly's sofe-m ADC stakes a claim in ovarian cancer

Eli Lilly's first major readout at ESMO comes from a phase 1 trial of its FRα-targeting sofe-m in platinum-sensitive ovarian cancer (PSOC).

News

ESMO26: Evidence for GSK's mo-rez builds in ovarian cancer

New data from GSK's BEHOLD-1 study of B7-H4-targeted ADC mo-rez reinforces earlier results in platinum-resistant ovarian cancer.

News

PMV cues up filing for first p53-directed cancer therapy

PMV is preparing to file for approval of its first-in-class oral p53 protein reactivator, rezatopopt, for ovarian cancer in the first quarter of 2027.

Oncology

Solving the ovarian cancer diagnostic and treatment pathway ...

News

Moderna shows in vivo CAR-T hand in R&D update

At its latest R&D update, Moderna revealed a move into the pioneering in vivo CAR-T category, adding another treatment class to its R&D capabilities.

News

AbbVie's ovarian cancer drug Elahere gets NHS green light

AbbVie's Elahere has become the first new NHS therapy in more than 20 years for resistant ovarian cancer, providing an alternative to chemotherapy.

ESMO26: Lilly's sofe-m ADC stakes a claim in ovarian cancer

ESMO26: Evidence for GSK's mo-rez builds in ovarian cancer

PMV cues up filing for first p53-directed cancer therapy

Solving the ovarian cancer diagnostic and treatment pathway ...

Moderna shows in vivo CAR-T hand in R&D update

AbbVie's ovarian cancer drug Elahere gets NHS green light

UK backs startup Potential Sciences' AI-powered drug hunt

Discover a new era of healthcare panel engagement: Grounded ...

ovarian cancer

Editor's Picks